St. Jude Medical, Inc. (STJ) Tops Q2 EPS by 2c; Guides Q3, FY14

St. Jude Medical, Inc. (NYSE: STJ) reported Q2 EPS of $1.02, $0.02 better than the analyst estimate of $1.00. Revenue for the quarter came in at $1.45 billion versus the consensus estimate of $1.44 billion.

St. Jude Medical, Inc. sees Q3 2014 EPS of $0.95-$0.97, versus the consensus of $0.96. St. Jude Medical, Inc. sees Q3 2014 revenue of $1.315-1.395 billion, versus the consensus of $1.40 billion.

St. Jude Medical, Inc. sees FY2014 EPS of $3.96-$4.01, versus the consensus of $3.99. St. Jude Medical, Inc. sees FY2014 revenue of $5.64-5.76 billion, versus the consensus of $5.70 billion.

For earnings history and earnings-related data on St. Jude Medical, Inc. (STJ) click here.

You May Also Be Interested In

• North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
• Logistic Properties of the Americas (LPA) Reports Q2 results
• Acrivon Therapeutics, Inc. (ACRV) Tops Q2 EPS by 21c